Sandoz Group AG (SDZNY)
OTCMKTS
· Delayed Price · Currency is USD
44.78
-0.21 (-0.47%)
Nov 21, 2024, 3:50 PM EST
Sandoz Group AG Revenue
Sandoz Group AG had revenue of $5.06B in the half year ending June 30, 2024, with 8.28% growth. This brings the company's revenue in the last twelve months to $10.11B, up 5.75% year-over-year. In the year 2023, Sandoz Group AG had annual revenue of $9.98B with 7.23% growth.
Revenue (ttm)
10.11B
Revenue Growth
+5.75%
P/S Ratio
n/a
Revenue / Employee
446.74K
Employees
22,633
Market Cap
19.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 9.98B | 673.00M | 7.23% |
Dec 31, 2022 | 9.31B | -372.00M | -3.84% |
Dec 31, 2021 | 9.68B | 20.00M | 0.21% |
Dec 31, 2020 | 9.66B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSandoz Group AG News
- 3 days ago - Agomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of Directors - Business Wire
- 6 days ago - Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio - GlobeNewsWire
- 22 days ago - Sandoz reports third-quarter and nine-month 2024 sales - GlobeNewsWire
- 5 weeks ago - Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio - GlobeNewsWire
- 6 weeks ago - Sandoz Canada achieves carbon neutral certification for its commercial operations - GlobeNewsWire
- 2 months ago - Sandoz Group: Moving To A 'Hold' After A 50% Move - Seeking Alpha
- 3 months ago - Axsome Therapeutics reaches agreement to dismiss patent litigation with Sandoz - Seeking Alpha
- 3 months ago - Axsome Therapeutics reaches agreement to dismiss patent litigation with Sandoz - Seeking Alpha